Abstract Background Drug-coated balloons (DCBs) are an established strategy for coronary artery disease. However. the new generation drug-eluting stent (DES) is recommended for patients with Acute myocardial infarction (AMI) for coronary artery revascularization. Our aim is to provide a comprehensive appraisal of the efficacy of DCBs in patients with AMI undergoing PCI. https://megavitamines.shop/product-category/kidney-formulas/